Pharma marketers face a tricky balance: they need patient and prescriber data to run targeted campaigns, but strict privacy rules limit how that data can be used. A new playbook from Experian, promoted via MedCity News, lays out a workflow that starts with governed onboarding—getting data into a marketing system in a way that respects consent and regulatory requirements.
The playbook then moves from onboarding to outcomes, using what it calls partner-enabled measurement. That means working with approved partners to measure whether campaigns actually influence prescribing behavior or patient engagement, rather than just tracking clicks. The goal is a privacy-first approach that still delivers measurable results.
Because this is a sponsored post, the recommendations come from Experian itself, not from independent research. Still, the framework highlights a growing industry shift: identity resolution in pharma is becoming less about matching cookies and more about governed, consent-based data activation across the healthcare ecosystem.